IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Ikarian Capital, LLC

Q1 2023 Holdings

Filed 2023-05-15 | 117 holdings | $440.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Morphic Hldg IncCallCOM61775R105$8.0M213,4001.8%
Insmed Inc(INSM)COM PAR $.01457669307$8.3M485,0001.9%
Vaxcyte Inc(PCVX)COM92243G108$8.4M225,0001.9%
Terns Pharmaceuticals Inc(TERN)COM880881107$8.5M721,3411.9%
Biomea Fusion Inc(BMEA)CallCOM09077A106$9.0M291,0002.0%
Reata Pharmaceuticals Inc(RETAEUR)CallCL A75615P103$9.1M100,0002.1%
Bridgebio Pharma Inc(BBIO)CallCOM10806X102$9.1M549,6002.1%
Axsome Therapeutics Inc(AXSM)CallCOM05464T104$9.3M150,0002.1%
Axsome Therapeutics Inc(AXSM)PutCOM05464T104$9.3M150,0002.1%
Bridgebio Pharma Inc(BBIO)COM10806X102$9.9M594,6862.2%
Merck & Co Inc(MRK)COM58933Y105$10.6M100,0002.4%
Astria Therapeutics Inc(CATBUSD)COM04635X102$11.6M869,3902.6%
Immunovant Inc(IMVT)COM45258J102$12.0M774,3982.7%
Prometheus Biosciences IncCOM74349U108$13.5M125,9263.1%
Intra-Cellular Therapies Inc(ITCIEUR)CallCOM46116X101$20.6M380,0004.7%
Sarepta Therapeutics Inc(SRPT)CallCOM803607100$28.3M205,4006.4%
Sarepta Therapeutics Inc(SRPT)PutCOM803607100$37.4M271,3008.5%
PreviousPage 3 of 3